Lv1
50 积分 2026-02-08 加入
Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro Data
20天前
已完结
Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro Data
21天前
已完结
Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19
27天前
已完结
Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19
3个月前
已完结